ARCHIMED is a private equity investment firm founded in 2014 and headquartered in Lyon, France. The firm specializes exclusively in the healthcare sector, investing in companies across biopharma products, consumer health, healthcare IT, in vitro diagnostics, life science tools & biologic services, medtech, and pharma services. With offices in Europe, North America, and Asia, ARCHIMED manages billions in assets and aims to support the growth and internationalization of its portfolio companies.